Anti-SARS-CoV-2 and anticancer properties of triptolide and its derived carbonized nanomaterials
Rubina Kousar,
No information about this author
Tahira Akhtar,
No information about this author
Chin‐Jung Lin
No information about this author
et al.
Cancer Letters,
Journal Year:
2025,
Volume and Issue:
unknown, P. 217677 - 217677
Published: March 1, 2025
Language: Английский
Developing Zika virus-transduced hACE2 expression models for severe acute respiratory syndrome coronavirus 2 infection in vitro and in vivo
Joh-Sin Wu,
No information about this author
Ju-Ying Kan,
No information about this author
Young-Sheng Chang
No information about this author
et al.
Journal of Virological Methods,
Journal Year:
2025,
Volume and Issue:
336, P. 115166 - 115166
Published: April 14, 2025
Language: Английский
Design and Application of Biosafe Coronavirus Engineering Systems without Virulence
Viruses,
Journal Year:
2024,
Volume and Issue:
16(5), P. 659 - 659
Published: April 24, 2024
In
the
last
twenty
years,
three
deadly
zoonotic
coronaviruses
(CoVs)—namely,
severe
acute
respiratory
syndrome
coronavirus
(SARS-CoV),
Middle
East
(MERS-CoV),
and
SARS-CoV-2—have
emerged.
They
are
considered
highly
pathogenic
for
humans,
particularly
SARS-CoV-2,
which
caused
2019
CoV
disease
pandemic
(COVID-19),
endangering
lives
health
of
people
globally
causing
unpredictable
economic
losses.
Experiments
on
wild-type
viruses
require
biosafety
level
3
or
4
laboratories
(BSL-3
BSL-4),
significantly
hinders
basic
virological
research.
Therefore,
development
various
biosafe
systems
without
virulence
is
urgently
needed
to
meet
requirements
different
research
fields,
such
as
antiviral
vaccine
evaluation.
This
review
aimed
comprehensively
summarize
engineering
systems.
These
combine
foundations
with
synthetic
genomics
techniques,
enabling
efficient
tools
attenuated
non-virulent
vaccines,
screening
drugs,
investigation
mechanisms
novel
microorganisms.
Language: Английский
Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants
Uyen Nguyen Phuong Le,
No information about this author
Yu-Jen Chang,
No information about this author
Chih‐Hao Lu
No information about this author
et al.
Antiviral Research,
Journal Year:
2024,
Volume and Issue:
227, P. 105920 - 105920
Published: May 29, 2024
Language: Английский
RNA replication-independent, DNA linearization-dependent expression of reporter genes from a SARS-CoV-2 replicon-encoding DNA in human cells
Ronja Friedhoff,
No information about this author
Ghada Elfayres,
No information about this author
Natacha Mérindol
No information about this author
et al.
PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(8), P. e0300491 - e0300491
Published: Aug. 16, 2024
Replicons,
derived
from
RNA
viruses,
are
genetic
constructs
retaining
essential
viral
enzyme
genes
while
lacking
key
structural
protein
genes.
Upon
introduction
into
cells,
the
carried
by
replicon
expressed,
and
self-replicates,
yet
particle
production
does
not
take
place.
Typically,
replicons
transcribed
in
vitro
then
electroporated
cells.
However,
it
would
be
advantageous
for
to
generated
cells
following
DNA
transfection
instead
of
RNA.
In
this
study,
a
bacterial
artificial
chromosome
(BAC)
encoding
SARS-CoV-2
under
control
T7
promoter
was
transfected
HEK293T
engineered
functionally
express
polymerase
(T7
RNAP).
BAC
DNA,
we
observed
low,
but
reproducible
expression
reporter
proteins
GFP
luciferase
replicon.
Expression
required
linearization
prior
transfection.
Moreover,
occurred
independently
RNAP.
Gene
also
insensitive
remdesivir
treatment,
suggesting
that
did
involve
self-replication
Similar
results
were
obtained
highly
infection-permissive
Calu-3
Strikingly,
N
boosted
DNA.
conclusion,
large
coronaviral
led
gene
through
an
unidentified
mechanism.
These
findings
highlight
novel
pathway
toward
cDNA,
offering
valuable
insights
development
methods
DNA-based
applications.
Language: Английский
Assessing the inhibitory effects of some secondary amines, thioureas and 1,3-dimethyluracil conjugates of (-)-cytisine and thermopsine on the RNA-dependent RNA polymerase of SARS-CoV-1 and SARS-CoV-2
Bioorganic & Medicinal Chemistry Letters,
Journal Year:
2024,
Volume and Issue:
113, P. 129950 - 129950
Published: Sept. 7, 2024
Language: Английский
A novel SARS-CoV-2-derived infectious vector system
Ghada Elfayres,
No information about this author
Yong Xiao,
No information about this author
Qinghua Pan
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 16, 2024
Abstract
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
the
causative
agent
of
COVID-19.
The
development
antiviral
drugs
for
COVID-19
has
been
hampered
by
requirement
a
biosafety
level
3
(BSL3)
laboratory
experiments
related
to
SARS-CoV-2,
and
lack
easy
precise
methods
quantification
infection.
Here,
we
developed
SARS-CoV-2
viral
vector
composed
all
four
structural
proteins
constitutively
expressed
in
lentivirally
transduced
cells,
combined
with
an
RNA
replicon
deleted
protein
genes
S,
M
E,
expressing
luciferase-GFP
fusion
protein.
We
show
that,
after
concentrating
stocks
ultracentrifugation,
able
infect
two
human
cell
lines
receptors
ACE2
TMPRSS2.
Both
luciferase
activity
GFP
fluorescence
were
detected,
transduction
was
remdesivir-sensitive.
also
that
this
inhibited
three
type
I
interferons
(IFN-I)
subtypes.
Although
improvements
are
needed
increase
infectious
titers,
system
may
prove
useful
drug
screening
SARS-CoV-2-related
investigations.
Language: Английский